Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In France, vaccination coverage is insufficient (in 2002, 71.2% coverage for tetanus, 41.9% for poliomyelitis and 33.7% for diphteria). These numbers decrease significantly with age: coverage for people aged over 65 was 60.5%, 13.3% and 10.5% for tetanus, poliomyelitis and diphteria coverage respectively.
The primary objective of this study is to evaluate the impact of a hospital based vaccination remedial strategy for Tdap-IPV (tetanus, diphteria, pertussis and polio vaccine) in patients 65 years of age or older.
Secondary objectives are to measure the vaccination coverage of patients aged 65 years or older hospitalised in a medical ward in our hospital, to evaluate their knowledge of their vaccination coverage, and to evaluate the socio-demographic factors associated with vaccination coverage.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention arm | Active Comparator |
|
|
| Standard care | No Intervention |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Remedial vaccination | Biological |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in immunization rate after a hospital centered remedial strategy for Tdap-IPV vaccination in patients 65 years or older | Difference in the increase in vaccination coverage between the two arms, measured as a percentage | two months |
| Measure | Description | Time Frame |
|---|---|---|
| Immunisation rate among patients 65 years of age or older in the Sarthe department of France | Pre-intervention vaccination coverage rate in both arms, measured as a percentage | two months |
| Immunisation rate according to sex among patients 65 years or older |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sophie Blanchi, M.D. | Centre Hospitalier du Mans | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre Hospitalier Le Mans | Le Mans | 72 000 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Single center, prospective, cluster randomized trial.
Not provided
Not provided
Not provided
Not provided
|
Sex of patients included in the study |
| two months |
| Immunisation rate according to primary care coverage among patients 65 years of age or older | Primary care coverage is defined as having a regular primary care physician registered as such with French social security. | two months |
| Immunisation rate according to socio professional category | Socio professional category defined according to the French national institute for statistics and economic studies (INSEE) | two months |